Lotus Eye Hospital and Institute Limited has informed the Exchange regarding Board meeting held on August 12, 2025.
LOTUSEYE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Directors of Lotus Eye Hospital and Institute Limited approved unaudited standalone financial results for the quarter ended June 30, 2025. Total income for Q1 FY26 stood at Rs. 1,370.45 lakhs, with revenue from operations at Rs. 1,351.69 lakhs, compared to Rs. 1,319.68 lakhs in Q1 FY25, indicating modest year-on-year growth of about 2.4%. Net profit for the quarter came in at Rs. 54.48 lakhs (down from Rs. 60.90 lakhs in Q1 FY25), translating to EPS of Rs. 0.26. However, on a quarter-on-quarter basis, net profit more than doubled from Rs. 25.23 lakhs in Q4 FY25. The statutory auditors (Anbarasu & Jalapathi) have conducted a limited review and found no material misstatements in the results.
Mixed signals for shareholders — revenue showed slight year-on-year growth but net profit declined ~10.5% YoY, largely due to higher employee and operating expenses. The strong sequential recovery from Q4 FY25 may provide some near-term support, though margin pressure remains a concern.